DUBLIN--(BUSINESS WIRE)--The "Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.
Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Vaso-Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Vaso-Occlusive Crisis Associated With Sickle Cell Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Unknown stages are 3, 4, 1, 1, 1 and 1 respectively.
Vaso-Occlusive Crisis Associated With Sickle Cell Disease (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Key Topics Covered:
- Introduction
- Report Coverage
- Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Overview
- Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Therapeutics Development
- Pipeline Overview
- Pipeline by Companies
- Products under Development by Companies
- Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Therapeutics Assessment
- Assessment by Target
- Assessment by Mechanism of Action
- Assessment by Route of Administration
- Assessment by Molecule Type
- Vaso-Occlusive Crisis Associated With Sickle Cell Disease - Companies Involved in Therapeutics Development
- Asklepion Pharmaceuticals LLC
- AstraZeneca Plc
- Bristol-Myers Squibb Co
- Gilead Sciences Inc
- Global Blood Therapeutics Inc
- Modus Therapeutics AB
- Novartis AG
- NuvOx Pharma LLC
- Pfizer Inc
- Prolong Pharmaceuticals LLC
- Seattle Genetics Inc
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/rwfgtn/vasoocclusive?w=4
